Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

    NEXT STORY
    Basilea reports marketing authorization of antifungal Cresemba® in Brazil
    PREV STORY
    Editas Medicine Appoints Judith R. Abrams, M.D., as Chief Medical Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria

    LEXINGTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging ...

    author_avatar
    NASDAQ Market News

    Magnus Persson to Resign from Immunicum’s Board of Directors

    author_avatar
    NASDAQ Market News

    XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with OnivydeⓇ and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer

    AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment ...

    author_avatar
    NASDAQ Market News